Magazine Article | December 1, 2022

Biopharma Public Opinion, Pricing, Politics

Source: Life Science Leader

By Wayne Koberstein, Executive Editor, Life Science Leader
Follow Me On Twitter @WayneKoberstein

The concept of biopharma-industry sustainability has evolved to include how the public views the policies and actions of biopharma companies regarding matters such as workforce diversity, responsibility to patients, and even political affiliations. Neutrality or tradition no longer suffice to protect companies in the current battles over science and anti-science, sexual and gender politics, the environment, public health, and other contested issues.

access the Magazine Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

Please tell us more about you so that we can customize our newsletters to your specific interests: